Home » Topics » BioWorld Science

BioWorld Science
RSS

Mitsui Chemicals reports anilide derivatives useful as antiarrhythmic agents

Aug. 8, 2001

Novel acylquinoline derivative developed for antiulcer applications

Aug. 8, 2001

Rigel and Novartis begin collaboration to discover antiangiogenic agents

Aug. 8, 2001

Endorex acquires CTD and adds two clinical-stage products to its pipeline

Aug. 8, 2001

FDA grants fast track status to TransMID-107R for the treatment of brain cancer

Aug. 8, 2001

Novasite Pharmaceuticals and Aventis enter evaluation agreement

Aug. 8, 2001

Genzyme receives marketing authorization for Fabrazyme

Aug. 8, 2001

Questcor sells shares of common stock to Sigma-Tau

Aug. 8, 2001

Noven signs product development agreement with Novartis for combination HRT patches

Aug. 8, 2001

First kidney transplant patient enrolled in phase II trials of ISAtx-247

Aug. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...